Skip to main content
Premium Trial:

Request an Annual Quote

DoubleTwist Signs Host of New Subscribers in Q2

NEW YORK, July 11 – DoubleTwist of Oakland, Calif., said Wednesday that in the second quarter of 2001 it had signed more than 10 new subscribers to its genomic data and analysis tools available through DoubleTwist.com.

The news comes on the heels of a similar announcement made in April in which DoubleTwist said that it had signed 20 new subscribers in the first quarter of the year.

DoubleTwist did not comment on the subscription fees the new users were paying and a spokesperson was not immediately available for comment.

The spate of good news seems to mark a turnaround for the company, which was forced to cancel its IPO due to poor market conditions. Later, DoubleTwist cut its staff, triggering questions about whether or not the company would survive.

The new customers include Cedars Sinai Medical Center, DeveloGen, Icagen, Laboratoires Fournier, MD Anderson Cancer Center, The National Cancer Institute, Organon, Oxagen, Pherin Pharmaceuticals, Provalis, Switch Biotech, The University of California at Davis, The University of Reading, The Weizmann Institute of Science, and a number of unnamed organizations in Europe and Asia.
 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.